The Total Hip Replacement (THR) market has evolved from a procedure reserved for the elderly into a life-changing intervention for active individuals across all age groups. As a leading THR factory and exporter, we observe that the global demand is driven by an aging population, rising rates of osteoarthritis, and the increasing prevalence of hip dysplasia. Today, the industry is not just about manufacturing hardware; it's about biomechanical engineering that mimics natural human movement.
In developed regions like North America and Europe, the focus has shifted toward longevity and material science. Surgeons are demanding implants that can last 25+ years, leading to the rise of highly cross-linked polyethylene and ceramic-on-ceramic bearings. Meanwhile, in emerging markets, the priority is accessibility and cost-effective quality. This creates a massive commercial opportunity for specialized factories capable of balancing high-tech R&D with manufacturing efficiency.
Global procurement trends indicate a shift toward integrated solutions—where hospitals seek not just the prosthesis, but the complete surgical instrument sets, power tools, and post-operative digital tracking tools. As a comprehensive THR supplier, we bridge this gap by providing full-spectrum orthopedic solutions.
Years Experience
Exporting Countries
Global Clients
Factory Area (㎡)
Integration of sensors within the femoral stem to monitor gait analysis and early signs of implant loosening or infection.
Custom-made implants designed from CT scans to fit the unique anatomy of patients with severe bone loss or deformities.
Manufacturing specialized instrument sets that are compatible with robotic surgical arms for sub-millimeter precision.
The application of Total Hip Replacement technology has expanded into the veterinary sector. High-end veterinary clinics in the UK, USA, and Germany are now performing THR on large-breed dogs suffering from hip dysplasia. This niche market requires specialized, smaller-scale implants and precision power tools.
Our factory produces Veterinary THR systems that utilize the same medical-grade Titanium and Cobalt-Chrome alloys as human implants, ensuring our four-legged patients receive the same standard of care. This cross-industry application is a major growth driver for our export business.
As a leading orthopedic implant manufacturer in Chengdu, China, we offer a unique combination of advanced manufacturing technology and cost efficiency. Chengdu has become a biotech hub, providing us with access to top-tier engineering talent and a robust supply chain for medical-grade raw materials like Ti6Al4V alloy and CoCrMo.
Global procurement managers are increasingly looking for "Value-Based Procurement". They need products that pass all clinical safety standards but are priced at a level that allows public healthcare systems to expand access to hip replacement surgery. This is where Chengdu Medev excels, offering premium medical instruments that compete with Western brands on quality while offering significant cost savings.
Chengdu Medev Medical Instruments Co., Ltd. was founded in 2001, covers an area of 18,000 ㎡, including a floor area of over 15,000 ㎡. Its registered capital reaches 20 million Yuan. which is specialized in product research, design and manufacturing of orthopedic implant instruments. As the leader in orthopedic implants and instruments manufacturing, We have been successfully supplying to 1000+ clients in 120+ countries for over 20 years thanks to extensive know-how and expertise. We adhere to the ‘people-oriented, integrity first, continuous innovation, the pursuit of excellence,’ the concept of guarding human health!
Cleaned implants have a cleaner surface, helping to reduce the risk of post-operative infection. Ensures that the implant is safer to apply to the patient during surgery.
Tests the tensile strength, yield strength and elongation of materials. Simulates the tensile forces to which the implant is subjected in the body.
Packaging should ensure a good seal to prevent the entry of external contaminants. Use heat sealing, pressing or gluing to ensure the integrity of the package.
In the realm of Total Hip Replacement (THR), the technical requirements for manufacturing are exceptionally rigorous. As a specialized factory, we focus on the two primary types of fixation: cemented and cementless. Cementless stems, which are favored in many Western markets for younger patients, require a bioactive coating—often hydroxyapatite (HA) or a titanium plasma spray—to encourage bone ingrowth. This process requires a sophisticated cleanroom environment and high-precision spraying equipment to ensure the coating thickness is consistent within microns.
From a commercial perspective, the THR industry is currently undergoing a "Digital Transformation." This means that the physical implant is no longer the only product. Hospitals are looking for pre-operative planning software and patient-specific instruments (PSI). As an exporter, we have adapted by offering custom instrument sets that align with modern surgical protocols. This technical adaptability makes our factory a preferred partner for international medical distributors who require rapid prototyping and high-volume production capabilities.
The global procurement demand is also shifting toward sustainability and supply chain resilience. Since the 2020 global disruptions, many European and North American hospitals have sought to diversify their suppliers, moving away from a reliance on a single geographic region. China’s medical device manufacturing sector has stepped up to fill this need, offering ISO-certified reliability and massive production capacity that can withstand global market fluctuations.
Furthermore, the localized application scenarios for THR are increasingly varied. In Southeast Asia, there is a growing demand for "Asian-Fit" femoral stems, which are designed to accommodate the generally smaller femoral canals found in Asian populations compared to Western counterparts. Our R&D team works closely with local surgeons in different regions to modify designs, ensuring that the "one size fits all" approach is replaced by "anatomically optimized" solutions.
For industrial buyers, Total Hip Replacement procurement involves more than just unit price. It involves evaluating the manufacturer's long-term stability, their R&D roadmap, and their post-market surveillance capabilities. Chengdu Medev provides comprehensive clinical data support and technical documentation (Technical Files) to help our partners navigate the complex regulatory landscapes of the CE, FDA, and other regional health authorities.
In conclusion, whether you are a hospital procurement officer in Brazil, a medical device distributor in Dubai, or a veterinary specialist in Australia, our THR factory offers the precision, quality, and technological innovation required to drive successful clinical outcomes. We are not just an exporter; we are your strategic partner in the future of orthopedic medicine.
Medev Medical
